Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00550342
What this trial is testing

Rituximab Treatment of Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Ended earlyNCT04074330
What this trial is testing

TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Takeda 38
Testing effectiveness (Phase 2)Study completedNCT00005601
What this trial is testing

Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 58
Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Ended earlyNCT00391066
What this trial is testing

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Biogen 627
Testing effectiveness (Phase 2)Study completedNCT01859819
What this trial is testing

Treatment for Advanced B-Cell Lymphoma

Who this might be right for
Diffuse Large Cell LymphomaBurkitt's LymphomaHigh Grade B-cell Lymphoma
New York Medical College 45
Early research (Phase 1)Study completedNCT00244946
What this trial is testing

Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute 15
Testing effectiveness (Phase 2)Looking for participantsNCT04989803
What this trial is testing

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Who this might be right for
Relapsed and/or Refractory B-cell Lymphoma
Kite, A Gilead Company 247
Early research (Phase 1)Study completedNCT00110071
What this trial is testing

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+12 more
Fred Hutchinson Cancer Center 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04419519
What this trial is testing

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
Memorial Sloan Kettering Cancer Center 81
Early research (Phase 1)Study completedNCT01205737
What this trial is testing

A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects

Who this might be right for
DLBCL
Teva Branded Pharmaceutical Products R&D, Inc. 186
Early research (Phase 1)Looking for participantsNCT07439263
What this trial is testing

Single Ascending Dose Study of HB2198 in Healthy Participants

Who this might be right for
Healthy Volunteer
Hinge Bio 32
Testing effectiveness (Phase 2)Ended earlyNCT00058461
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Burkitt LymphomaChildhood Diffuse Large Cell Lymphoma+6 more
National Cancer Institute (NCI) 82
Early research (Phase 1)Study completedNCT02776813
What this trial is testing

Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Lymphoma
Cogent Biosciences, Inc. 34
Testing effectiveness (Phase 2)WithdrawnNCT00006669
What this trial is testing

Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Medstar Health Research Institute
Testing effectiveness (Phase 2)Study completedNCT00003397
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Maryland, Baltimore 25
Not applicableUnknownNCT03045471
What this trial is testing

The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma

Who this might be right for
To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
Shanghai Public Health Clinical Center 50
Early research (Phase 1)Looking for participantsNCT06395870
What this trial is testing

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma-RecurrentB-Cell Non-Hodgkin Lymphoma-Refractory
Tianjin Medical University Cancer Institute and Hospital 33
Testing effectiveness (Phase 2)UnknownNCT05704400
What this trial is testing

Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Istituto Giannina Gaslini 20
Large-scale testing (Phase 3)Study completedNCT00848692
What this trial is testing

Drug Intervention in Chronic Fatigue Syndrome

Who this might be right for
Chronic Fatigue Syndrome
Haukeland University Hospital 30
Next Page